Jos Jansen

Chapter 1 24 European Liver Transplant Registry (ELTR) - 50-year evolution of liver transplantation. Transplant international : official journal of the European Society for Organ Transplantation. 2018;31(12):1293-317. 38. Kowdley KV, Brown KE, Ahn J, Sundaram V. ACG Clinical Guideline: Hereditary Hemochromatosis. The American journal of gastroenterology. 2019;114(8):1202-18. 39. Patel D, Teckman JH. Alpha-1-Antitrypsin Deficiency Liver Disease. Clin Liver Dis. 2018;22(4):643- 55. 40. Roberts EA, Schilsky ML, American Association for Study of Liver D. Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008;47(6):2089-111. 41. Gunaydin M, Bozkurter Cil AT. Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment. Hepat Med. 2018;10:95-104. 42. Hansen K, Horslen S. Metabolic liver disease in children. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2008;14(4):391-411. 43. Lelieveld SH, Veltman JA, Gilissen C. Novel bioinformatic developments for exome sequencing. Human genetics. 2016. 44. Lek M, al. e. Analysis of protein-coding genetic variation in 60,706 humans. bioRxiv. 2015. 45. Thusberg J, Olatubosun A, Vihinen M. Performance of mutation pathogenicity prediction methods on missense variants. Human mutation. 2011;32(4):358-68. 46. Gilissen C, Hoischen A, Brunner HG, Veltman JA. Disease gene identification strategies for exome sequencing. European journal of human genetics : EJHG. 2012;20(5):490-7. 47. Parla JS, Iossifov I, Grabill I, Spector MS, Kramer M, McCombie WR. A comparative analysis of exome capture. Genome biology. 2011;12(9):R97. 48. Lelieveld SH, Spielmann M, Mundlos S, Veltman JA, Gilissen C. Comparison of Exome and Genome Sequencing Technologies for the Complete Capture of Protein-Coding Regions. Human mutation. 2015;36(8):815-22. 49. Lupski JR, Reid JG, Gonzaga-Jauregui C, Rio Deiros D, Chen DC, Nazareth L, et al. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. The New England journal of medicine. 2010;362(13):1181-91. 50. van Dijk EL, Jaszczyszyn Y, Naquin D, Thermes C. The Third Revolution in Sequencing Technology. Trends in genetics : TIG. 2018;34(9):666-81. 51. Gilissen C, Hehir-Kwa JY, Thung DT, van de Vorst M, van Bon BW, Willemsen MH, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014;511(7509):344-7. 52. Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Science translational medicine. 2011;3(65):65ra4. 53. MacArthur DG, Manolio TA, Dimmock DP, Rehm HL, Shendure J, Abecasis GR, et al. Guidelines for investigating causality of sequence variants in human disease. Nature. 2014;508(7497):469-76. 54. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in medicine : official journal of the American College of Medical Genetics. 2015;17(5):405-24. 55. Guillard M, Wada Y, Hansikova H, Yuasa I, Vesela K, Ondruskova N, et al. Transferrin mutations at the glycosylation site complicate diagnosis of congenital disorders of glycosylation type I. Journal of inherited metabolic disease. 2011;34(4):901-6. 56. Guillard M, Morava E, van Delft FL, Hague R, Korner C, Adamowicz M, et al. Plasma N-glycan